Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The value of serum amyloid A for predicting the severity and recovery of COVID‑19

7 Aug 2020

Abstract excerpt

The present study aimed to evaluate the value of serum amyloid A (SAA) in coronavirus disease 2019 (COVID‑19) and compared the efficacy of SAA and C‑reactive protein (CRP) in predicting the severity and recovery of COVID‑19. A retrospective study was conducted on COVID‑19 patients hospitalized in Wuhan No. 1 Hospital (Hubei, China) from January 21, 2020 to March 4, 2020. A two‑way ANOVA analysis was used to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Pancreatitis Pathology and Treatment
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32855710
DOI: 10.3892/etm.2020.9114

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The value of serum amyloid A for predicting the severity and recovery of COVID‑19PMID 32855710Read ↗

Features of C-reactive protein in COVID-19 patients within various period: a cohort studySemantic proximity Read ↗

Features of C-reactive protein in COVID-19 patients with different ages, clinical types and outcomes: a cohort studySemantic proximity Read ↗

The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective studySemantic proximity Read ↗

Neurotoxic Amyloidogenic Peptides in the Proteome of SARS-COV2: Potential Implications for Neurological Symptoms in COVID-19Semantic proximity Read ↗

Systemic amyloidosis journey from diagnosis to outcomes: a twelve-year real-world experience of a single center in a middle-income countrySemantic proximity Read ↗

Neurotoxic Amyloidogenic Peptides Identified in the Proteome of SARS-COV2: Potential Implications for Neurological Symptoms in COVID-19Semantic proximity Read ↗

SARS-CoV-2 infection induces the production of autoantibodies in severe COVID-19 patients in an age-dependent mannerSemantic proximity Read ↗

A Tool to Early Predict Severe Corona Virus Disease 2019 (COVID-19) : A Multicenter Study using the Risk Nomogram in Wuhan and Guangdong, ChinaSemantic proximity Read ↗

Natural history, hospitalizations and mortality causes in ATTRv V30M amyloidosis in an endemic European cohortSemantic proximity Read ↗

Low serum level of apolipoprotein A1 is an indicator of severity in patients with coronavirus disease 2019Semantic proximity Read ↗

Low serum apolipoprotein A 1 is an indicator of severity in patients with coronavirus disease 2019Semantic proximity Read ↗

Performance of serum apolipoprotein-A1 as a sentinel of Covid-19Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.